In India, two vaccines, Kovishield and Kovacin, have been allowed for emergency use to eradicate the corona virus, and actual vaccination has begun. Millions of health workers have been vaccinated so far. In the meantime, India will now get another vaccine to fight the corona virus. The vaccine will also be able to eradicate the new corona virus.
Adar Poonawalla, CEO of the Serum Institute of India in Pune, which is producing Oxford and AstraZene covshield vaccines, said on Saturday. Serum has entered into an agreement with US company Novavax Inc for this. Adar Punawala also said that an application would be made to the government to start a trial of the new vaccine soon.
The name will be ‘Covavax’
Meanwhile, the new vaccine will be called Covavax. The vaccine will be 89 percent effective against the new strain of the corona virus (strain). The vaccine is expected to be launched in India by June 2021.
– SerumInstituteIndia (@SerumInstIndia) January 30, 2021
The company claims
The vaccine, launched in the UK, also includes Novavax Inc. Preliminary findings show that the vaccine is 88 percent effective against new strains. The vaccine is effective against the new strain of corona, which is spreading rapidly in Britain and South Africa, and works to rapidly boost immunity in patients, the company claims.
1 crore 10 lakh doses of Kovishield purchased
Meanwhile, the central government has already given permission for emergency use of Kovishield vaccine, which is already being produced by the Serum Institute of India. The vaccine was developed by the British-Swedish company Oxford-AstraZeneca. So far, the central government has procured 1 crore 10 lakh doses from the company.
Vaccination has started in India from January 16 and so far more than 20 lakh health workers and frontline workers have been vaccinated. In the second phase of vaccination, Prime Minister Narendra Modi, Chief Ministers of various states and key leaders will also be vaccinated.